Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HOWARD KENNEY

NPI
1780754671
CMS profile
172076
Location
SPOKANE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$19,882.11

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $14,962.50 7
Food and Beverage $3,956.76 115
Travel and Lodging $953.85 2
Education $9.00 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HOWARD KENNEY

NPI 1780754671 · CMS profile ID 172076

SPOKANE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780754671?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HOWARD KENNEY, NPI 1780754671, CMS profile ID 172076. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780754671?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). HOWARD KENNEY, NPI 1780754671, CMS profile ID 172076. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780754671?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
HOWARD KENNEY, NPI 1780754671, CMS profile ID 172076, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–125 of 125 matching records. This page contains 25 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1780754671?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $19,882.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–125 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $12.4303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019930901 CMS
PFIZER INC. $5.7903/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050320907 CMS
ABBVIE INC. $15.0103/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997627423 CMS
ABBVIE INC. $124.7303/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997627425 CMS
Amgen Inc. $10.8103/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019930869 CMS
PFIZER INC. $10.5503/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049603821 CMS
UCB, Inc. $24.0303/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021600641 CMS
ABBVIE INC. $32.4603/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997627421 CMS
Horizon Therapeutics plc $93.4602/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987029379 CMS
Lilly USA, LLC $93.1702/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031661497 CMS
UCB, Inc. $7.1202/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021600619 CMS
AstraZeneca Pharmaceuticals LP $24.1502/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025002195 CMS
Amgen Inc. $10.2202/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019930865 CMS
Alexion Pharmaceuticals, Inc. $9.0002/13/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025060809 CMS
Horizon Therapeutics plc $26.0002/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987029377 CMS
UCB, Inc. $3.2402/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021600585 CMS
UCB, Inc. $23.7602/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021600635 CMS
Janssen Biotech, Inc. $11.7501/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988757685 CMS
Janssen Biotech, Inc. $2.7001/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988757687 CMS
Lilly USA, LLC $31.5101/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031478311 CMS
ABBVIE INC. $119.8201/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997627419 CMS
SOBI, INC $17.8801/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038085255 CMS
ABBVIE INC. $34.6801/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997627417 CMS
PFIZER INC. $7.1701/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049121917 CMS
Amgen Inc. $16.5101/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020588787 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $37,166.97 214
PY2020 $3,555.19 46
PY2021 $29,805.74 87
PY2022 $31,011.32 138
PY2023 $19,882.11 125
PY2024 $6,027.50 144
PY2025 $4,951.38 151

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $114,114.62 57
PY2024 Principal investigator $286,829.81 18
PY2023 Principal investigator $51,620.09 13
PY2022 Principal investigator $26,550.28 8
PY2021 Principal investigator $126,982.20 11
PY2020 Recipient $1,524.78 7
PY2020 Principal investigator $304,800.94 44
PY2019 Principal investigator $281,878.03 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

57 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,500.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996187
Principal investigator 1 Ascendis Pharma Endocrinology Inc $602.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996219
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996251
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996253
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996255
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996257
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996259
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996261
Principal investigator 1 Ascendis Pharma Endocrinology Inc $480.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996263
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996385
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996387
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996389
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996391
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996393
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996395
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996397
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996399
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996401
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996403
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996405
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996407
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996409
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996411
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996477
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996479
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996481
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996483
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996485
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996487
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996489
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996491
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996493
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996495
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996497
Principal investigator 1 Ascendis Pharma Endocrinology Inc $47.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996499
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996507
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996509
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996511
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996513
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996515
Principal investigator 1 Ascendis Pharma Endocrinology Inc $39.00 07/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233996517
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,595.10 04/03/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
PaTHway TRIAL No dispute reported 06/30/2026 1233995287
Principal investigator 1 Ascendis Pharma Endocrinology Inc $19,949.80 03/26/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
PaTHway TRIAL No dispute reported 06/30/2026 1233995233
Principal investigator 1 Alexion Pharmaceuticals, Inc. $62,752.44 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST, PLLC
Eneboparatide - Calypso study which is a pivotal phase 3 study investigational therapeutic peptide with a novel mechanism of action for hypoparathyroidism No dispute reported 06/30/2026 1185540483
Principal investigator 1 Ascendis Pharma Endocrinology Inc $602.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995029
Principal investigator 1 Ascendis Pharma Endocrinology Inc $602.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995031
Principal investigator 1 Ascendis Pharma Endocrinology Inc $602.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995033
Principal investigator 1 Ascendis Pharma Endocrinology Inc $602.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995035
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995089
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995091
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995093
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995095
Principal investigator 1 Ascendis Pharma Endocrinology Inc $342.00 03/05/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233995097
Principal investigator 1 Ascendis Pharma Endocrinology Inc $2,500.00 02/07/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233994564
Principal investigator 1 Ascendis Pharma Endocrinology Inc $1,496.00 02/07/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
EAP of Palopegteriparatide in Patients With Hypoparathyroidism No dispute reported 06/30/2026 1233994570
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $7,784.10 01/27/2025 Non-covered Recipient Entity
Arthritis Northwest, Pllc
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus No dispute reported 06/30/2026 1235998874
Principal investigator 1 Ascendis Pharma Endocrinology Inc $2,871.18 01/23/2025 Non-covered Recipient Entity
ARTHRITIS NORTHWEST PLLC
PaTHway TRIAL No dispute reported 06/30/2026 1233994396